Gsk (GSK) Return on Equity [ROE] (2009 - 2026)
Gsk (GSK) reported Return on Equity [ROE] of 71.91% for the quarter ended Sep 30, 2026, up 21.97 percentage points from 49.94% a year earlier but down 5.72 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk posted Return on Equity [ROE] of 42.29%, up 20.20 percentage points from the prior year.
- Return on Equity [ROE] has a five-year change of +11.01 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Return on Equity [ROE] came in at 22.09% in the year ended Dec 31, 2024 (-22.26 pp), 44.35% in the year ended Dec 31, 2023 (-48.63 pp), 92.98% in the year ended Dec 31, 2022 (+68.45 pp) and 24.53% in the year ended Dec 31, 2021 (-6.76 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of 22.64% in the quarter ended Jun 30, 2022 and a high of 197.07% in the quarter ended Dec 31, 2022.
- Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +8.72 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was the quarter ended Dec 31, 2022 (a gain of 172.85 percentage points); the low point was the quarter ended Dec 31, 2023 (a drop of 123.08 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at 77.64% (quarter ended Jun 30, 2026), 90.55% (quarter ended Mar 31, 2026) and 93.15% (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | - |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | - |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 4.66% |
| 10 | Gsk | 108.79 Bn | 91.12 Bn | 8.73 Bn | 71.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 71.91% |
| Jun 30, 2026 | 77.64% |
| Mar 31, 2026 | 90.55% |
| Dec 31, 2025 | 93.15% |
| Sep 30, 2025 | 49.94% |
| Jun 30, 2025 | 35.07% |
| Mar 31, 2025 | 33.54% |
| Dec 31, 2024 | 28.32% |
| Sep 30, 2024 | 23.01% |
| Jun 30, 2024 | 34.80% |
| Mar 31, 2024 | 35.56% |
| Dec 31, 2023 | 40.76% |
| Sep 30, 2023 | 53.68% |
| Jun 30, 2023 | 143.29% |
| Mar 31, 2023 | 148.94% |
| Dec 31, 2022 | 185.45% |
| Sep 30, 2022 | 107.46% |
| Jun 30, 2022 | 22.80% |
| Mar 31, 2022 | 25.58% |
| Dec 31, 2021 | 24.23% |
API Access
Gsk Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();